Previous 10 | Next 10 |
NEW YORK, NY / ACCESSWIRE / December 9, 2023/ Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Cerevel Therapeutics Holdings, I...
2023-12-08 08:01:47 ET More on AbbVie, Cerevel, etc. Cerevel Stock Soars Ahead Of Parkinson's Drug Update - I'm On Sidelines AbbVie: 4 Hidden Keys Investors Must Know To Judge ImmunoGen Acquisition AbbVie: Risky Purchase Of ImmunoGen Could Pay Off Big Time Ab...
2023-12-08 05:38:00 ET These days, it seems like biotech buyout offers are falling from the sky. During the week ended Dec. 6, AbbVie (NYSE: ABBV) announced not one but two big acquisitions. The pharma giant's latest big buyout offer is for Cerevel Therapeutics (NASDAQ: CE...
2023-12-07 13:02:39 ET Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) jumped some 12% today after AbbVie Inc (NYSE: ABBV) said it will buy the drug company that focuses primarily on neurological disorders. AbbVie seems to be on a buying spree AbbVie is willing to spend about $...
2023-12-07 08:47:08 ET More on Karuna, Reviva, etc. Karuna Therapeutics: Rewiring The Schizophrenia Paradigm - A Novel Leap Beyond Dopamine Karuna Therapeutics, Inc. (KRTX) Q3 2023 Earnings Conference Call Transcript Reviva Pharmaceuticals: Positive Results In Phase ...
2023-12-07 08:27:08 ET MicroAlgo ( MLGO ) +74% plans to establish a practice base to train graduate students for the university. Altisource Asset Management ( AAMC ) +23% Asset case against six defendants in suit v. BlackRock, Pimco can proceed. ...
2023-12-07 05:00:05 ET Related stock stories: Chewy, Inc. (CHWY) Q3 2023 Earnings Call Transcript C3.ai, Inc. (AI) Q2 2024 Earnings Call Transcript Cerevel Stock Soars Ahead Of Parkinson's Drug Update - I'm On Sidelines GameStop in charts: Sales slip Y/Y for ...
CERE MERGER ANNOUNCEMENT: Julie & Holleman LLP Announces Investigation Into Potential Claims Regarding AbbVie's Proposed Acquisition of Cerevel Therapeutics CERE MERGER ANNOUNCEMENT: Julie & Holleman LLP Announces Investigation Into Potential Claims Regarding AbbVie's Proposed A...
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline PR Newswire Proposed acquisition adds robust pipeline of assets focused on best-in-class potential for psychiatric and neurological disorders where significant unmet needs ...
2023-12-06 16:06:57 ET More on Cerevel Therapeutics Cerevel Stock Soars Ahead Of Parkinson's Drug Update - I'm On Sidelines Cerevel Therapeutics: High Standards And Development Burden Poses Reflexivity Risks Cerevel Therapeutics Holdings, Inc. (CERE) Q3 2023 Earnings...
News, Short Squeeze, Breakout and More Instantly...
2024-07-10 10:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-20 12:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, NY / ACCESSWIRE / May 29, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Cerevel Therapeutics Holdings, Inc. ("Cerevel") (NASDAQ:CERE) and AbbVie, Inc. ("AbbVie") (NYSE:ABBV). Investors who purchased Cerevel and continue to holdto the present are enco...